首页> 美国卫生研究院文献>Malaria Journal >A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections
【2h】

A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections

机译:一种从干血斑中提取核酸的新方法可用于超低密度检测恶性疟原虫和间日疟原虫感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundGreater Mekong Subregion countries are committed to eliminating Plasmodium falciparum malaria by 2025. Current elimination interventions target infections at parasite densities that can be detected by standard microscopy or rapid diagnostic tests (RDTs). More sensitive detection methods have been developed to detect lower density “asymptomatic” infections that may represent an important transmission reservoir. These ultrasensitive polymerase chain reaction (usPCR) tests have been used to identify target populations for mass drug administration (MDA). To date, malaria usPCR tests have used either venous or capillary blood sampling, which entails complex sample collection, processing and shipping requirements. An ultrasensitive method performed on standard dried blood spots (DBS) would greatly facilitate the molecular surveillance studies needed for targeting elimination interventions.
机译:背景大湄公河次区域国家致力于在2025年前消除恶性疟原虫疟疾。目前的消除干预措施以标准显微镜或快速诊断测试(RDT)可以检测到的寄生虫感染为目标。已经开发出了更灵敏的检测方法,以检测可能代表重要传播源的低密度“无症状”感染。这些超灵敏的聚合酶链反应(usPCR)测试已用于鉴定大规模药物管理(MDA)的目标人群。迄今为止,疟疾usPCR测试已使用静脉或毛细管血液采样,这需要复杂的样本收集,处理和运输要求。在标准干血斑(DBS)上执行的超灵敏方法将极大地促进针对消除干预措施所需的分子监测研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号